Reshma Rangwala - Apr 22, 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
EVP & Chief Medical Officer
Signature
/s/Nancy Smith as Attorney-in-Fact for Reshma Rangwala
Stock symbol
KPTI
Transactions as of
Apr 22, 2024
Transactions value $
-$7,943
Form type
4
Date filed
4/23/2024, 04:02 PM
Previous filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$7.94K -6.79K -1.94% $1.17 343K Apr 22, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.